Cas 391671-85-5,L-Proline, 4-hydroxy-1-(2-naphthalenylsulfonyl)-, phenylmethyl ester, (4R)-

391671-85-5

Post Buying Request

Basic information

Product Name: L-Proline, 4-hydroxy-1-(2-naphthalenylsulfonyl)-, phenylmethyl ester, (4R)-
Synonyms:
CAS NO:391671-85-5
Molecular Formula: C22H21NO5S
Molecular Weight: 411.478
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: L-Proline, 4-hydroxy-1-(2-naphthalenylsulfonyl)-, phenylmethyl ester, (4R)-(CAS DataBase Reference)
NIST Chemistry Reference: L-Proline, 4-hydroxy-1-(2-naphthalenylsulfonyl)-, phenylmethyl ester, (4R)-(391671-85-5)
EPA Substance Registry System: L-Proline, 4-hydroxy-1-(2-naphthalenylsulfonyl)-, phenylmethyl ester, (4R)-(391671-85-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 391671-85-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

391671-85-5 Suppliers

Recommended suppliers

391671-85-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 391671-85-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,1,6,7 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 391671-85:
(8*3)+(7*9)+(6*1)+(5*6)+(4*7)+(3*1)+(2*8)+(1*5)=175
175 % 10 = 5
So 391671-85-5 is a valid CAS Registry Number.

391671-85-5Upstream product

391671-85-5Downstream Products

391671-85-5Relevant academic research and scientific papers

Pyrrolidine derivatives

-

, (2008/06/13)

The present invention relates to pyrrolidine derivatives and dimeric forms and/or pharmaceutically acceptable esters, and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 391671-85-5